Needed Research into Rare Form of NHL   Leave a comment

Splenic Marginal Zone Lymphoma (SMZL) is a rare form of non-Hodgkin’s Lymphoma that accounts for less than 3% of all cases of lymphoma. As a result, much less time has been spent on researching the cancer and, of course, much less is known about it.

Thankfully, though, England’s University of Southampton has gotten funding that will allow it to use state-of-the-art technology to search through a patient’s genes and determine the mutations that cause SMZL. With that knowledge the researchers aim to reveal what they refer to as the “genetic signs” that are linked to particularly bad prognoses. They will then be able to help doctors direct treatment accordingly.

The head of the research team, Dr. Jonathan Strefford, says:

“Finding these gene mutations will increase our understanding of how SMZL progresses and allow us to predict patient prognosis. These predictions can then be taken into account by doctors to ensure that those with a more aggressive disease are given the treatment that they need.”


Posted August 3, 2012 by lymphomactivist in NHL, Research

Tagged with , , ,

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: